MSP Recovery Debuts Tomorrow

by | May 23, 2022

Medicare/Medicaid secondary payer reimbursement recovery specialist trades tomorrow. And the rest of the day’s news in SPACs.

Free Investor Resources from Boardroom Alpha
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

LCAP /MSP Recovery closes; MSPR trades tomorrow

Lionheart Acquisition Corporation II (LCAP) completes combination Medicare and Medicaid secondary payer reimbursement recovery leader MSP Recovery. MSPR begins trading tomorrow, 5/24.

Tigra Acquisition Corp. (TINV) / Grindr extends

Tigra Acquisition Corp. (TINV) confirms funding extension deadline to 11/27. SPAC adds another $2.76M / $0.10 to trust. The SPAC has a pending DA with Grindr.

OTEC extends deadline

OceanTech Acquisitions I Corp. (OTEC) uses its sole 6 month extension to extend to 12/2/2022. The SPAC will add $1.5M to trust, or $0.15 – bringing current NAV to ~$10.25. OTEC intends to focus its search on target businesses in the leisure marine, yachting and superyachting industries, and with enterprise values of approximately $250 million to $1.0 billion.

Elsewhere in SPACs

Source: Boardroom Alpha

Heat Map: SPACs with Announced Transactions

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Recent Analysis

Daily SPAC Update – July 23, 2024

Chainbridge + Phytanix Bio $58M Deal Announced. PWUP + Visiox Pharmaceuticals Deal Terminated. ASCB Extension Approved. OCAX Delisted. ZLS Owes $81K to Stay Listed. 

Daily SPAC Update – July 19, 2024

AIBAF DeSPACs to PSIG. GAMC Sets Deal Vote. NOVV and BYNO Extension Votes Set. BlueRiver Acquisition  (BLUAF) Suspends Trading. CCIV Vote Moves to August.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.